OrganophosphonatesLamivudineDideoxynucleosidesAdenineAnti-HIV AgentsDeoxycytidineHIV InfectionsRitonavirReverse Transcriptase InhibitorsHIV-1ZidovudineBenzoxazinesDrug Therapy, CombinationViral LoadAntiretroviral Therapy, Highly ActiveHepatitis B, ChronicDrug Resistance, ViralAntiviral AgentsTreatment FailureDrug CombinationsLipodystrophyOxazinesDidanosineIntention to Treat AnalysisDrug Resistance, Multiple, ViralHepatitis B virusNevirapineStavudineHIV Reverse TranscriptaseTreatment OutcomeHepatitis B e AntigensAnti-Retroviral AgentsLopinavirHIV Protease InhibitorsCD4 Lymphocyte CountDrug HypersensitivityNucleosidesVaginal Creams, Foams, and JelliesHIVRNA, ViralArea Under CurveHepatitis BTherapeutic EquivalencyPyrrolidinonesChemopreventionPhosphorous AcidsIndinavirHLA-B AntigensDNA, ViralDrug Administration ScheduleAlanine TransaminaseOrganophosphorus CompoundsPregnancy Complications, InfectiousPyrimidinonesMutationPyridinesOligopeptidesHepatitis B Surface AntigensAdministration, OralDrug InteractionsMedication AdherenceSimian Acquired Immunodeficiency SyndromeProspective StudiesDouble-Blind MethodGuanineAdministration, IntravaginalCarbamatesFanconi SyndromeGenotypeTabletsHepatitis B AntibodiesDose-Response Relationship, DrugGene Products, polInfectious Disease Transmission, VerticalHIV-Associated Lipodystrophy SyndromeInterferon-alphaNelfinavirZalcitabineCoagulantsPolyethylene GlycolsLiver TransplantationStandard of CareChromatography, High Pressure LiquidAnti-Infective Agents, Local